BioNTech founder says cancer is next problem to tackle with mRNA tech | The Hill: Healthcare Policy

The co-founder of German company BioNTech, which successfully delivered the first widely distributed coronavirus vaccine, said that the mRNA technology it used will soon be put to work tackling cancer.Özlem Türeci, who ...